longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Mingyue Optical Lens

301101

28.591.07% ( -0.31 )
Delay Trading: Sep 10, 13:20:15
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 27.93, below the reasonable range, cheaper than 92.46% of the time in the past 3 years, and the industry ranks 12/41, the industry Median 30.42.

27.93xP/E
¥28.90Stock price
¥1.03Earnings per share
27.93xP/E
Stock price¥28.90Earnings per share¥1.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
42.21x
Typical range
30.70x–49.79x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 30.42x
020406080

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 30.42x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300832SZSnibe
22.49x14.62%¥38.61B
300677SZINTCO
30.96x140.45%¥35.22B
300888SZWinner Medical
21.64x24.24%¥17.08B
688029SHMTM
28.23x1.90%¥14.41B
301371SZFuerjia
24.01x19.28%¥11.02B
300595SZAUTEK
21.01x8.32%¥9.69B
301580SZAIDITE TECH.
38.75x29.35%¥8.09B
688050SHEyebright Medical
32.00x28.81%¥7.60B
301101SZMingyue Optical Lens
27.93x16.53%¥5.82B
002950SZAllmed Medical
23.57x--¥5.72B
688606SHAlltest
24.91x--¥3.46B
603205SHJEK
30.42x--¥3.46B
688338SHSucceeder
36.95x63.53%¥3.11B
688013SHTouchstone
38.17x--¥1.94B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.